Literature DB >> 34533655

Honorary Professor Garry Graham.

Richard O Day1,2, Kenneth M Williams3, Kieran F Scott4,5.   

Abstract

An appreciation of the contribution of Professor Gary Graham to anti-inflammatory and antirheumatic pharmacology and clinical pharmacology.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Allopurinol; Enantiomers; Gold; Ibuprofen; Nonsteroidal anti-inflammatory drugs; Paracetamol; Pharmacokinetics; Salicylates

Mesh：

Substances：

Year:  2021        PMID： 34533655     DOI： 10.1007/s10787-021-00872-1

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN： 0925-4692            Impact factor:   4.473


  34 in total

Review 1.  Variability in response to NSAIDs. Fact or fiction?

Authors:  R O Day; G G Graham; K M Williams; P M Brooks
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

Review 2.  Pharmacokinetics of non-steroidal anti-inflammatory agents.

Authors:  G D Champion; G G Graham
Journal:  Aust N Z J Med       Date:  1978

Review 3.  Anti-rheumatic drug interactions.

Authors:  R O Day; G G Graham; G D Champion; E Lee
Journal:  Clin Rheum Dis       Date:  1984-08

4.  Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.

Authors:  R O Day; J O Miners; D J Birkett; A Whitehead; D Naidoo; J Hayes; E Savdie
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

5.  Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol.

Authors:  R O Day; J Miners; D J Birkett; G G Graham; A Whitehead
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

6.  Concentration-response relationships for salicylate-induced ototoxicity in normal volunteers.

Authors:  R O Day; G G Graham; D Bieri; M Brown; D Cairns; G Harris; J Hounsell; S Platt-Hepworth; R Reeve; P N Sambrook
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

7.  Salicylate metabolite kinetics after several salicylates.

Authors:  F Bochner; G G Graham; B E Cham; D M Imhoff; T M Haavisto
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

8.  Interaction of salicylate and corticosteroids in man.

Authors:  R O Day; G Harris; M Brown; G G Graham; G D Champion
Journal:  Br J Clin Pharmacol       Date:  1988-09       Impact factor: 4.335

9.  Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis.

Authors:  G D Champion; D R Cairns; D Bieri; M A Adena; C D Browne; M L Cohen; R O Day; J P Edmonds; G G Graham; J de Jager
Journal:  J Rheumatol       Date:  1988-01       Impact factor: 4.666

10.  Changes in salicylate serum concentration and metabolism during chronic dosing in normal volunteers.

Authors:  R O Day; D E Furst; S H Dromgoole; H E Paulus
Journal:  Biopharm Drug Dispos       Date:  1988 May-Jun       Impact factor: 1.627
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.